Wegovy is the semaglutide product licensed specifically for chronic weight management, and for many people it is the right first choice. But it is not the only option, and there are three common reasons to look elsewhere: cost, tolerability, and wanting greater results. This guide covers the alternatives to Wegovy across each of those, with the evidence and the actual prices.

Quick Takeaway:

• Zepbound (tirzepatide) has produced greater average weight loss in trials — roughly 16.5%–22.4% versus around 15% for Wegovy
• The Wegovy Pill offers oral semaglutide for those who want to avoid injections
• Foundayo (orforglipron) is a separate oral GLP-1 from Eli Lilly
• NovoCare® self-pay has been offered at $349–$499 against a Wegovy list price of around $1,349
• Non-GLP-1 options produce 5%–10% weight loss at a fraction of the cost

Looking for a Better Alternative?

The provider you choose determines what you pay and how well you are supported. CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy, combining competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources.

Why we recommend CoreAge Rx:

• Lower monthly costs than most competitors ($179–$399 range)
• Faster prescription approval (typically 12–24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. No insurance required.

Reason 1: You Want Greater Weight Loss

Zepbound (tirzepatide) is the standard alternative. It activates both the GLP-1 and GIP receptors rather than GLP-1 alone, and produced roughly 16.5% to 22.4% mean weight loss over 72 weeks in trials, depending on dose, against around 15% at 68 weeks for semaglutide 2.4 mg.

Switching is clinically routine when response to semaglutide has been inadequate. Doses are not equivalent between the two, so your prescriber sets a starting point rather than matching milligrams.

Our semaglutide versus tirzepatide comparison covers the evidence in detail.

Reason 2: You Cannot Tolerate It

Gastrointestinal side effects — nausea, vomiting, diarrhoea, constipation — are the leading cause of discontinuation, and they cluster in the two weeks after each dose increase.

Before switching medication entirely, consider these in order:

1. Hold at your current dose. Staying at a tolerable dose indefinitely is legitimate clinical practice and far better than quitting. Ask your prescriber.
2. Step back one level. Also legitimate. There is no prize for reaching 2.4 mg.
3. Slow the titration. Six or eight weeks between increases rather than four.
4. Then consider switching. Some patients genuinely tolerate tirzepatide better than semaglutide, or vice versa — individual response varies.

See our side effects guide for management strategies.

Reason 3: The Cost

Wegovy's list price is around $1,349 per month in the US. Almost nobody should be paying that.

In the UK, Wegovy programme pricing runs roughly £99 per pen at ZAVA, £149–£249 at Second Nature, and from £164 at Juniper — generally cheaper than equivalent Mounjaro tiers. NHS access via NICE criteria costs the prescription charge or nothing if exempt.

Pro Tip: Novo Nordisk's launch pricing for Wegovy on NovoCare was flat across all dose strengths. That is structurally better than dose-tiered pricing if you expect to need a high maintenance dose, because escalating costs you nothing extra.

Reason 4: You Want to Avoid Injections

• Wegovy Pill — oral semaglutide, the same molecule in tablet form. Offered by Sesame from $149/month, Hims & Hers, ZAVA, and Boots. ZAVA's guidance indicates patients on 7.5 mg+ Mounjaro can usually switch to the pill's maximum maintenance dose.
• Foundayo (orforglipron) — Eli Lilly's oral GLP-1, a different molecule, distributed through LillyDirect, Amazon Pharmacy, telehealth providers, and pharmacies. Second Nature offers a Foundayo programme at £129–£179/month.

Reason 5: You Cannot Take a GLP-1

Absolute contraindications — personal or family history of medullary thyroid carcinoma, MEN2 syndrome, pregnancy, breastfeeding — rule the class out entirely. Alternatives:

Frequently Asked Questions

What is a stronger alternative to Wegovy?

Zepbound, which contains tirzepatide. It produced roughly 16.5% to 22.4% mean weight loss over 72 weeks in trials depending on dose, compared with around 15% at 68 weeks for semaglutide 2.4 mg. Individual response varies substantially.

Is there a cheaper alternative to Wegovy?

Yes. Against a list price of around $1,349, NovoCare® has offered self-pay at $349–$499, the Wegovy Pill has been offered from $149/month through Sesame, and bundled compounded telehealth programmes run roughly $179–$400 all in. Insurance coverage is cheaper than all of these.

Can I take Wegovy as a tablet?

Yes. The Wegovy Pill is oral semaglutide, offered by several telehealth providers and pharmacies. A separate oral GLP-1, orforglipron, is marketed by Eli Lilly as Foundayo.

What if Wegovy makes me too nauseated?

Discuss holding at your current dose, stepping back one level, or slowing the titration schedule before considering a switch. These are all standard clinical strategies and are far better than discontinuing. Some patients do tolerate tirzepatide better, which is a legitimate reason to switch.

Is Ozempic an alternative to Wegovy?

They contain the same molecule, semaglutide, but Ozempic is licensed for type 2 diabetes rather than weight management and titrates to a lower maintenance dose. Using Ozempic for weight loss is off-label and less likely to be covered by insurance for that purpose.

What are the non-GLP-1 alternatives?

Phentermine/topiramate (around 8%–10% weight loss), naltrexone/bupropion (around 5%–9%), and orlistat (around 5%). Structured behavioural programmes and bariatric surgery are also established options.

Bottom Line

If Wegovy is working and affordable, staying on it is reasonable. If it is not, the alternative depends on why.

For greater results, tirzepatide. For side effects, hold or reduce your dose before switching drugs. For cost, NovoCare self-pay at $349–$499, the Wegovy Pill from $149, or a bundled programme from $179 — and check your insurance formulary first, because coverage beats all of them. For needle aversion, oral GLP-1s now exist. And if the class is contraindicated for you, several other treatments produce meaningful, sustainable results.

CoreAge Rx offers both semaglutide and tirzepatide with all-in monthly pricing from $179–$399 including medication, provider messaging, and titration support. 12–24 hour approvals. Save up to $200 on your first three months.

Medical disclaimer: Informational only, not medical advice. All medications discussed carry risks and contraindications. Never switch, adjust, or stop a GLP-1 without your prescriber's direction. Consult a qualified healthcare professional.

Sources: FDA prescribing information for Wegovy, Zepbound, Ozempic, and Mounjaro; NovoCare® and LillyDirect published self-pay pricing; provider published pricing pages; NICE obesity management guidance.

Date reviewed: August 2026